arrow
C

Cédric Pastoret

laboratoire d'hematologie
H指数:18
被引数:1,112

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Blinatumomab consolidation for high-risk Ph-negative B-cell acute lymphoblastic leukemia: the GRAALL-2014/B-QUEST study

Blinatumomab巩固治疗高风险Ph阴性B细胞急性淋巴细胞白血病:GRAALL-2014/B-QUEST研究

Blood
IF23.1
2026-04-280
PRE
Age‐adapted chemotherapy and MRD‐oriented transplant for Ph-negative acute lymphoblastic leukemia - GRAALL-2014 trial

年龄适应化疗和微小残留病导向移植治疗Ph阴性急性淋巴细胞白血病——GRAALL-2014试验

Blood
IF23.1
2025-10-280
PRE
Venetoclax and azacitidine for molecular relapse after intensive chemotherapy in NPM1 or CBF AML: a FILO study

Venetoclax和azacitidine用于NPM1或CBF AML在密集化疗后的分子复发:一项FILO研究

2025-08-210
OAAI
Oncogenomic profiling in infant-toddler T-ALL identifies NKX2 family genes as drivers linked to favorable outcomes

婴幼儿t-all的肿瘤基因组分析将NKX2家族基因确定为与有利结果相关的驱动因素

2025-05-270
OA
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX

阿扎胞苷治疗VEXAS综合征的疗效与安全性:FRENVEX小组的一项大规模回顾性研究

Blood
IF23.1
2025-05-190
PRE
Implementation science in hemato-oncology molecular diagnostics in France via the Groupe des Biologistes Moléculaire des Hémopathies Malignes (GBMHM)

法国通过恶性血液病分子生物学小组(Groupe des Biologistes Moléculaire des Hémopathies Malignes, GBMHM)在血液肿瘤分子诊断领域的转化研究。

2025-04-080
OAAI
Targeted therapies overcome the poor prognosis of stereotyped Subset#2 chronic lymphocytic leukemia : a real-world multicentric study

靶向治疗克服了类型#2慢性淋巴细胞白血病的较差预后:一项真实世界多中心研究

LEUKEMIA
IF13.4
2025-04-010
OA
A Clinicopathological Description of Kidney Features in VEXAS Syndrome
2025-01-010
OAAI
CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM
2024-02-250
OAAI
Hepatosplenic T-cell lymphoma displays an original oyster-shell cytological pattern and a genomic profile distinct from that of γδ T-cell large granular lymphocytic leukemia
2024-01-250
OAAI
The Broad Spectrum of TP53 Mutations in CLL: Evidence of Multiclonality and Novel Mutation Hotspots
2023-05-090
OAAI
Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis
2023-01-1014
OAAI